You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Seattle Genetics

Showing 1 - 25 of 1,107
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Boston, Seattle (HIV-1 DNA plasmid vaccine, HIV-1 recombinant Ad5 vaccine)

Completed
  • HIV Infections
  • HIV-1 DNA plasmid vaccine
  • HIV-1 recombinant Ad5 vaccine
  • Boston, Massachusetts
  • +1 more
Oct 13, 2021

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome Trial in Worldwide (Miransertib)

Terminated
  • PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome
  • Atlanta, Georgia
  • +10 more
May 10, 2022

Rett Syndrome Trial in United States (Trofinetide, Placebo)

Completed
  • Rett Syndrome
  • Birmingham, Alabama
  • +20 more
Oct 28, 2022

Fragile X Syndrome Trial in Australia, New Zealand, United States (ZYN002 - Cannabidiol Transdermal Gel)

Enrolling by invitation
  • Fragile X Syndrome
  • ZYN002 - Cannabidiol Transdermal Gel
  • Phoenix, Arizona
  • +21 more
Aug 18, 2022

Glycogen Storage Disease Type II, Pompe Disease Trial in Worldwide

Recruiting
  • Glycogen Storage Disease Type II
  • Pompe Disease
    • Birmingham, Alabama
    • +274 more
    Jan 12, 2023

    Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Trial in Indianapolis, Boston (Eplontersen)

    Recruiting
    • Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
    • Indianapolis, Indiana
    • +19 more
    Jan 31, 2023

    Triple Negative Breast Cancer Trial in United States (Cisplatin, Paclitaxel)

    Active, not recruiting
    Has Results
    • Triple Negative Breast Cancer
    • Birmingham, Alabama
    • +19 more
    Feb 14, 2022

    Rett Syndrome Trial in United States (Trofinetide)

    Active, not recruiting
    • Rett Syndrome
    • Birmingham, Alabama
    • +20 more
    Nov 29, 2021

    Phenylketonuria (PKU) Trial in United States (BMN165 20mg/day, BMN165 40mg/day, Placebo)

    Completed
    Has Results
    • Phenylketonuria (PKU)
    • BMN165 20mg/day
    • +2 more
    • La Jolla, California
    • +28 more
    Apr 29, 2021

    Infertility, Aneuploidy Trial in Worldwide (Preimplantation Genetic Screening by NGS)

    Completed
    Has Results
    • Infertility
    • Aneuploidy
    • Preimplantation Genetic Screening by NGS
    • Tempe, Arizona
    • +37 more
    May 1, 2020

    Mucopolysaccharidosis VI Clinical Surveillance Program

    Completed
    • Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome)
      • Irvine, California
      • +49 more
      Apr 2, 2021

      Chronic Pancreatitis Trial in Russian Federation, Ukraine, United States (NI-03, Placebo)

      Completed
      • Chronic Pancreatitis
      • Little Rock, Arkansas
      • +47 more
      Dec 14, 2022

      Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

      Not yet recruiting
      • Lymphoma, T-Cell, Cutaneous
      • +5 more
      • (no location specified)
      Nov 2, 2023

      HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

      Not yet recruiting
      • Urothelial Carcinoma
        • (no location specified)
        Jun 5, 2023

        Colorectal Tumors, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial (SGN-EGFRd2)

        Not yet recruiting
        • Colorectal Neoplasms
        • +3 more
        • (no location specified)
        Aug 1, 2023

        Colorectal Tumors, NSCLC, Stomach Tumors Trial (SGN-CEACAM5C)

        Not yet recruiting
        • Colorectal Neoplasms
        • +5 more
        • (no location specified)
        Nov 9, 2023

        Cutaneous Melanoma, NSCLC, Colorectal Tumors Trial in Denver (SGN-BB228)

        Recruiting
        • Cutaneous Melanoma
        • +4 more
        • Denver, Colorado
          Sarah Cannon Research Institute at HealthONE - Denver
        Jan 17, 2023

        Hodgkin Lymphoma, Peripheral T Cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in United States (brentuximab vedotin)

        Terminated
        • Hodgkin Lymphoma
        • +2 more
        • brentuximab vedotin
        • Anaheim, California
        • +18 more
        Dec 6, 2022

        Multiple Myeloma Trial in United States (SEA-BCMA, dexamethasone, pomalidomide)

        Recruiting
        • Multiple Myeloma
        • Palo Alto, California
        • +10 more
        Aug 24, 2022

        Melanoma, NSCLC Trial in United States (brentuximab vedotin, pembrolizumab)

        Recruiting
        • Melanoma
        • +2 more
        • Tucson, Arizona
        • +31 more
        Jan 20, 2023

        Cutaneous Melanoma, Pleural Mesothelioma, HER2 Negative Breast Tumors Trial in Worldwide (SGN-CD228A)

        Active, not recruiting
        • Cutaneous Melanoma
        • +5 more
        • Birmingham, Alabama
        • +13 more
        Jan 23, 2023

        Urothelial Carcinoma Trial (disitamab vedotin, pembrolizumab, gemcitabine)

        Not yet recruiting
        • Urothelial Carcinoma
        • disitamab vedotin
        • +4 more
        • (no location specified)
        Jun 9, 2023

        Ovarian Tumors, Endometrial Tumors, NSCLC Trial in United Kingdom, United States (SGN-ALPV)

        Recruiting
        • Ovarian Neoplasms
        • +5 more
        • Fresno, California
        • +10 more
        Jan 20, 2023

        Selinexor in Relapsed or Refractory Multiple Myeloma - SEATTLE-

        Recruiting
        • Multiple Myeloma
        • Wien, Austria
        • +1 more
        Jul 13, 2023

        NSCLC, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma Trial in San Antonio, West Valley City,

        Recruiting
        • Carcinoma, Non-Small-Cell Lung
        • +4 more
        • San Antonio, Texas
        • +2 more
        Aug 15, 2022